Scarica l'app Stockscreener
4.20
3.00%
-0.13
Dopo l'orario di chiusura:
4.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GBIO Giù?
Forum
Previsione
Precedente Chiudi:
$4.33
Aprire:
$4.39
Volume 24 ore:
359.88K
Relative Volume:
3.45
Capitalizzazione di mercato:
$28.74M
Reddito:
-
Utile/perdita netta:
$-126.61M
Rapporto P/E:
-2.1429
EPS:
-1.96
Flusso di cassa netto:
$-60.14M
1 W Prestazione:
-19.45%
1M Prestazione:
+13.42%
6M Prestazione:
-55.20%
1 anno Prestazione:
-86.32%
Intervallo 1D:
$4.05
$4.61
Intervallo di 1 settimana:
$3.808
$4.6189
Portata 52W:
$3.004
$36.50
Generation Bio Co Stock (GBIO) Company Profile
Nome
Generation Bio Co
Settore
Industria
Telefono
857-529-5908
Indirizzo
301 BINNEY STREET, CAMBRIDGE
Confronta GBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
4.20 | 28.74M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-10-19 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-12-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-02-24 | Iniziato | William Blair | Outperform |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-07-07 | Iniziato | Cowen | Outperform |
| 2020-07-07 | Iniziato | JP Morgan | Overweight |
| 2020-07-07 | Iniziato | Jefferies | Buy |
| 2020-07-07 | Iniziato | Wedbush | Outperform |
Mostra tutto
Generation Bio Co Borsa (GBIO) Ultime notizie
Generation Bio Co. Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional
What analysts say about Generation Bio Co. stockBreakthrough wealth creation - Autocar Professional
Is Generation Bio Co. a good long term investmentConsistently exceptional gains - jammulinksnews.com
Why Generation Bio Co. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser
Company’s Banking Stock: Dissecting a 17.12% Quarterly Revenue Decline Amid Growth - investchronicle.com
Where Do Analysts Think The Generation Bio Co (NASDAQ: GBIO) Is Going - Stocksregister
Wedbush Raises Price Target on Generation Bio to $7 From $5, Keeps Outperform Rating - MarketScreener
Generation Bio’s (GBIO) “Outperform” Rating Reiterated at Wedbush - Defense World
What drives Generation Bio Co. stock priceTremendous growth potential - PrintWeekIndia
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates - MSN
Is Generation Bio Co. stock a good hedge against inflationFree Stock Market Forums - Newser
Generation Bio (NASDAQ:GBIO) Upgraded at Wall Street Zen - Defense World
Generation Bio shares rise 3.45% after-hours following a 1-for-10 reverse stock split announcement. - AInvest
Generation Bio to implement 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
Generation Bio to implement 1-for-10 reverse stock split - Investing.com Australia
Generation Bio Announces 1-for-10 Reverse Stock Split - The Manila Times
Generation Bio Plans 1-for-10 Reverse Split: What This Means for 67.3M Shares and Nasdaq Status - Stock Titan
What makes Generation Bio Co. stock price move sharplyHigh Reward Swing Trades - Newser
Generation Bio (NASDAQ:GBIO) Trading 13.9% Higher – Here’s Why - Defense World
How Generation Bio Co. stock performs during market volatilityMassive Profit Potential - Newser
Use AI to streamline lead generation and increase sales efficiencyFree Stock Market Forecasting Tools - Newser
There Is A Reason Generation Bio Co.'s (NASDAQ:GBIO) Price Is Undemanding - simplywall.st
Contrasting Compass Therapeutics (NASDAQ:CMPX) & Generation Bio (NASDAQ:GBIO) - Defense World
Layoff Tracker: Pacira Cuts 8% of San Diego Staff After Improving Manufacturing Efficiencies - BioSpace
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Generation Bio Grants Non-Statutory Stock Options to New Employee - AInvest
Generation Bio Announces Inducement Grant under Nasdaq Listing R - GuruFocus
Generation Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Barchart.com
Post Bio announced on the 17th that it held a kick-off event for the open innovation project and sig.. - 매일경제
64x Bio Launches AAV Apex Suite to Power the Next Generation of Gene Therapy Manufacturing - Business Wire
Millennium Management LLC Makes New $97,000 Investment in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Two Sigma Investments LP Sells 29,496 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Squarepoint Ops LLC Takes Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
What Did We Note About Insider Trading At Generation Bio Co (NASDAQ: GBIO)? - Stocksregister
Generation Bio Elects Directors and Approves Key Proposals - TipRanks
Generation Bio Co Azioni (GBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):